Finerenone receives Grade A Recommendation for treating CKD patients associated with type 2 diabetes: AACE update Dr. Kamal Kant Kohli10 Dec 2022 2:30 PMUSA: Bayer's KERENDIA (finerenone), a first-in-class non-steroidal mineralocorticoid receptor antagonist (ns-MRA) has received a grade A...
Roxadustat advantageous for improving anemia in chronic kidney disease Dr.Niharika Harsha B9 Dec 2022 2:30 PMA new study found that Roxadustat is very effective in improving anemia with no significant adverse events in patients with chronic kidney disease....
Toxemia Associated with Chronic Kidney Disease: Overview of role of Probiotics Dr Kartikeya Kohli9 Dec 2022 6:57 AMChronic kidney disease (CKD) affects between 8% and 16% of the global population and is frequently misdiagnosed by patients and professionals. CKD...
Atrasentan reduces triglycerides, albuminuria, and LDL-C in patients with type 2 diabetes and CKD Medha Baranwal8 Dec 2022 2:30 PMNetherlands: In high-risk patients with type 2 diabetes (T2D) and CKD (chronic kidney disease), atrasentan provides cardioprotection, is the...
Pre and Postoperative eGFR independent risk factor for CKD after Radical Nephrectomy Dr.Niharika Harsha B8 Dec 2022 2:00 PMA new study found that preoperative estimated glomerular filtration rate (eGFR), age, and immediate postoperative eGFR are independent risk factors...
Personalized kidney screening in type 1 diabetes tied to early detection and reduced testing frequency Medha Baranwal7 Dec 2022 5:30 AMUSA: Adopting a personalized approach alternative to annual screening for patients with type 1 diabetes (T1D) can considerably reduce the frequency of...
Microvascular complications of diabetes linked to pancreatic cancer Dr. Kamal Kant Kohli5 Dec 2022 4:30 AMCHINA: According to a study published in the Journal of the Endocrine Society, early-stage chronic kidney disease, a microvascular complication of...
Sarcopenic obesity elevates risk of CKD among diabetes patients Dr. Shravani Dali4 Dec 2022 2:30 PMSarcopenic obesity elevates risk of CKD among diabetes patients suggests a recent study published in the ObesityThis study aimed to investigate the...
HIF prolyl-hydroxylase inhibitors safe for anaemia treatment in CKD patients: Study Medha Baranwal1 Dec 2022 4:45 AMChina: A recent study has shed light on cardiac and kidney-related adverse effects of HIF-PHIs (hypoxia-inducible factor prolyl hydroxylase...
CDSCO nod to AstraZeneca Pharma Dapagliflozin tablets Ruchika Sharma28 Nov 2022 11:00 AMThe receipt of this permission paves way for the launch of Dapagliflozin (Forxiga) tablets of 10 mg in India for the specified additional/expanded...
Febuxostat demonstrates efficacy and renal safety in patients with gout and CKD Dr Supreeth D R23 Nov 2022 2:30 PMPeiyu Zhang et al conducted a study to explore the efficacy and renal safety of febuxostat in gout and stage 2-4 chronic kidney disease (CKD) and...
Persistent hematuria associated with strong risks of incident chronic kidney disease Dr. Kamal Kant Kohli22 Nov 2022 2:30 PMHematuria, which refers to the presence of blood in the urine, has been reported to be associated with increased risk of chronic kidney disease (CKD)....
